undamentalytics Newsletter
Sign in

Hedge fund

Pfm Health Sciences, LP

13F for June 30, 2026, filed August 14, 2026 · SEC CIK 1442756

Reported value
$1.2bn
99% in companies we cover
Positions we cover
95
Largest ASND 5.4%
Copy, a year
+11.1%
S&P 500 +13.6%
Copy Sharpe ratio
0.53
S&P 500 0.74

How copying its 13F would have done

$10.0k$20.0k$40.0k 2014201620182020202220242026 $50.2k$37.9k
CopyS&P 500 $10,000 copying Pfm Health Sciences, LP's filed holdings in companies we cover from February 28, 2014, buying on the first trading day after each 13F was filed and holding until the next, against the S&P 500 (total return). Marked weekly, log scale. Before costs and taxes; misses trading within each quarter and anything 13F does not show (shorts, cash, bonds, non-US holdings).

Biggest drop −28.2% (S&P 500 −31.8%); beta 0.94; alpha −1.0% a year (t = −0.29); last 12 months +30.1% against +12.1%.

Reported value by quarter

Pfm Health Sciences, LP: 13F reported value Total value of all positions in each quarter's 13F, as filed (values before 2023 were filed in thousands of dollars and are converted).
$0 $1T $2T $3T Reported value, 2013-03-31: $3B Reported value, 2013-06-30: $4.8B Reported value, 2013-09-30: $4.1B Reported value, 2013-12-31: $4.9B Reported value, 2014-03-31: $5.5B Reported value, 2014-06-30: $5B Reported value, 2014-09-30: $4.3B Reported value, 2014-12-31: $4.3B Reported value, 2015-03-31: $3.6B Reported value, 2015-06-30: $3.9B Reported value, 2015-09-30: $3.5B Reported value, 2015-12-31: $3.2B Reported value, 2016-03-31: $2.8B Reported value, 2016-06-30: $2.4B Reported value, 2016-09-30: $3B Reported value, 2016-12-31: $2.8B Reported value, 2017-03-31: $3.4B Reported value, 2017-06-30: $3.1B Reported value, 2017-09-30: $3.9B Reported value, 2017-12-31: $3.7B Reported value, 2018-03-31: $4.5B Reported value, 2018-06-30: $5.1B Reported value, 2018-09-30: $5.5B Reported value, 2018-12-31: $3.2B Reported value, 2019-03-31: $3.5B Reported value, 2019-06-30: $4.1B Reported value, 2019-09-30: $3.2B Reported value, 2019-12-31: $1.7B Reported value, 2020-03-31: $1.2B Reported value, 2020-06-30: $1.6B Reported value, 2020-09-30: $1.8B Reported value, 2020-12-31: $2.3B Reported value, 2021-03-31: $2.7B Reported value, 2021-06-30: $3B Reported value, 2021-09-30: $3B Reported value, 2021-12-31: $2.8B Reported value, 2022-03-31: $2.5B Reported value, 2022-06-30: $2.5B Reported value, 2022-09-30: $2.5B Reported value, 2022-12-31: $2.3T Reported value, 2023-03-31: $2.1B Reported value, 2023-06-30: $2.5B Reported value, 2023-09-30: $2B Reported value, 2023-12-31: $1.6B Reported value, 2024-03-31: $2B Reported value, 2024-06-30: $1.8B Reported value, 2024-09-30: $1.7B Reported value, 2024-12-31: $1.3B Reported value, 2025-03-31: $1.3B Reported value, 2025-06-30: $1.1B Reported value, 2025-09-30: $1.2B Reported value, 2025-12-31: $972.6M Reported value, 2026-03-31: $933.3M Reported value, 2026-06-30: $1.2B 2013-03-31 2015-12-31 2018-09-30 2021-06-30 2024-03-31 2026-06-30 $1.2B
View chart data
Period Reported value
2013-03-31 $3B
2013-06-30 $4.8B
2013-09-30 $4.1B
2013-12-31 $4.9B
2014-03-31 $5.5B
2014-06-30 $5B
2014-09-30 $4.3B
2014-12-31 $4.3B
2015-03-31 $3.6B
2015-06-30 $3.9B
2015-09-30 $3.5B
2015-12-31 $3.2B
2016-03-31 $2.8B
2016-06-30 $2.4B
2016-09-30 $3B
2016-12-31 $2.8B
2017-03-31 $3.4B
2017-06-30 $3.1B
2017-09-30 $3.9B
2017-12-31 $3.7B
2018-03-31 $4.5B
2018-06-30 $5.1B
2018-09-30 $5.5B
2018-12-31 $3.2B
2019-03-31 $3.5B
2019-06-30 $4.1B
2019-09-30 $3.2B
2019-12-31 $1.7B
2020-03-31 $1.2B
2020-06-30 $1.6B
2020-09-30 $1.8B
2020-12-31 $2.3B
2021-03-31 $2.7B
2021-06-30 $3B
2021-09-30 $3B
2021-12-31 $2.8B
2022-03-31 $2.5B
2022-06-30 $2.5B
2022-09-30 $2.5B
2022-12-31 $2.3T
2023-03-31 $2.1B
2023-06-30 $2.5B
2023-09-30 $2B
2023-12-31 $1.6B
2024-03-31 $2B
2024-06-30 $1.8B
2024-09-30 $1.7B
2024-12-31 $1.3B
2025-03-31 $1.3B
2025-06-30 $1.1B
2025-09-30 $1.2B
2025-12-31 $972.6M
2026-03-31 $933.3M
2026-06-30 $1.2B

Latest covered holdings and moves

Covered holdings as of June 30, 2026.

CompanyShare of portfolioValueSharesChange in shares
ASNDAscendis Pharma A/s5.40%$62.2m233.2KNew
AXSMAxsome Therapeutics, Inc.4.67%$53.8m219.6K−16.9% Reduced
LLYLilly (Eli)4.09%$47.1m39.3K−40.3% Reduced
JAZZJazz Pharmaceuticals plc3.36%$38.7m160.8K−9.8% Reduced
HUMHumana3.25%$37.5m94.4KNew
UNHUnitedHealth Group3.19%$36.7m88.3K+52.1% Added
NBIXNeurocrine Biosciences Inc3.12%$36.0m213.4K−1.1% Reduced
INBXInhibrx Biosciences, Inc.2.54%$29.2m308.4K+1.0% Added
UTHRUnited Therapeutics Corp2.35%$27.1m50.0K+25.6% Added
RVMDRevolution Medicines, Inc.2.33%$26.8m143.2K+1.7% Added
ICLRIcon PLC2.06%$23.7m136.5K+137.4% Added
THCTenet Healthcare Corp2.06%$23.7m126.6K−68.2% Reduced
EWEdwards Lifesciences1.97%$22.7m250.5K−1.6% Reduced
WATWaters Corporation1.95%$22.4m59.8K+50.5% Added
PENPenumbra Inc1.65%$19.0m60.2K−56.9% Reduced
BBIOBridgebio Pharma, Inc.1.64%$18.9m253.4K−1.7% Reduced
SYKStryker Corporation1.55%$17.8m56.6K+157.9% Added
MTDMettler Toledo1.48%$17.0m13.3KNew
INDVIndivior Pharmaceuticals, Inc.1.43%$16.5m401.2K−30.2% Reduced
MRKMerck & Co.1.42%$16.3m127.1KNew
CYTKCytokinetics Inc1.42%$16.3m191.7KNew
LNTHLantheus Holdings, Inc.1.41%$16.2m146.4KNew
CNCCentene Corporation1.39%$16.0m248.9K−5.5% Reduced
COOThe Cooper Companies1.38%$15.8m220.9K+30.1% Added
MDGLMadrigal Pharmaceuticals, Inc.1.37%$15.7m29.3K−14.2% Reduced
ACHCAcadia Healthcare Company, Inc.1.35%$15.5m524.9K−9.9% Reduced
ORKAOruka Therapeutics, Inc.1.31%$15.1m158.8K−8.7% Reduced
OSCROscar Health, Inc.1.28%$14.8m519.0K+3.8% Added
TMOThermo Fisher Scientific1.24%$14.3m28.5K+92.1% Added
CVSCVS Health1.24%$14.2m137.5KNew
MMSIMerit Medical Systems Inc1.19%$13.7m197.0K+21.3% Added
PRAXPraxis Precision Medicines, Inc.1.12%$12.9m38.6K+8.9% Added
CLDXCelldex Therapeutics, Inc.1.11%$12.8m342.8K+5.5% Added
NVONovo Nordisk A S1.10%$12.7m265.0K+34.4% Added
ITGRInteger Holdings Corp1.03%$11.8m126.7K−6.2% Reduced
DNTHDianthus Therapeutics, Inc.1.03%$11.8m121.2K−29.6% Reduced
DFTXDefinium Therapeutics, Inc.1.02%$11.7m249.0K+21.3% Added
GILDGilead Sciences1.00%$11.5m90.9KNew
RYTMRhythm Pharmaceuticals, Inc.0.98%$11.3m101.5K−25.7% Reduced
HSICHenry Schein0.97%$11.2m134.4K−12.2% Reduced
ARWRArrowhead Pharmaceuticals, Inc.0.93%$10.7m131.7K+104.8% Added
TNGXTango Therapeutics, Inc.0.89%$10.2m326.0K−19.7% Reduced
TFXTeleflex Inc0.88%$10.1m79.7KNew
VKTXViking Therapeutics, Inc.0.86%$10.0m255.3K−3.0% Reduced
BTSGBrightspring Health Services, Inc.0.86%$9.9m141.9K−24.2% Reduced
VERAVera Therapeutics, Inc.0.84%$9.6m224.3K+28.3% Added
ROIVRoivant Sciences Ltd.0.82%$9.5m268.0K+29.2% Added
CGONCG Oncology, Inc.0.79%$9.1m128.3K−22.7% Reduced
AMRXAmneal Pharmaceuticals, Inc.0.72%$8.3m480.7K−48.3% Reduced
EPRXEupraxia Pharmaceuticals Inc.0.69%$8.0m1.21M+123.8% Added
IRTCIrhythm Holdings, Inc.0.67%$7.8m65.2KNew
KODKodiak Sciences Inc.0.65%$7.5m193.3K+68.5% Added
ABTAbbott Laboratories0.65%$7.5m82.2K−41.4% Reduced
WSTWest Pharmaceutical Services0.65%$7.4m20.7KNew
HNGEHinge Health, Inc.0.60%$6.9m82.9KNew
ARQTArcutis Biotherapeutics, Inc.0.55%$6.3m242.1KNew
IARTIntegra Lifesciences Holdings Corp0.54%$6.3m348.7KNew
ILMNIllumina, Inc.0.54%$6.2m35.0K+21.4% Added
MGTXMeiragtx Holdings plc0.53%$6.2m455.3KNew
OCSOculis Holding AG0.53%$6.0m436.0KNew
NTRANatera, Inc.0.52%$6.0m22.1K−63.2% Reduced
ABVXAbivax S.a.0.50%$5.8m43.3K+62.3% Added
GHGuardant Health, Inc.0.48%$5.5m36.7KNew
CELCCelcuity Inc.0.47%$5.5m52.2KNew
BLTEBelite BIO, Inc0.47%$5.4m34.8K−41.4% Reduced
GPCRStructure Therapeutics Inc.0.43%$4.9m91.5K−27.6% Reduced
RCUSArcus Biosciences, Inc.0.41%$4.7m152.1KNew
CRLCharles River Laboratories0.37%$4.3m18.7KNew
ELANElanco Animal Health Inc0.37%$4.2m172.5KNew
ARGXArgenx SE0.36%$4.2m4.5K−1.2% Reduced
BIOBio-rad Laboratories, Inc.0.36%$4.1m14.0KNew
SYRESpyre Therapeutics, Inc.0.36%$4.1m46.2KNew
MBXMBX Biosciences, Inc.0.34%$3.9m71.0K−1.3% Reduced
MIRMMirum Pharmaceuticals, Inc.0.32%$3.7m31.5KNew
CGEMCullinan Therapeutics, Inc.0.30%$3.5m192.4K−15.4% Reduced
CMPSCompass Pathways plc0.30%$3.5m247.6K−81.9% Reduced
HCAHCA Healthcare0.28%$3.2m8.3K−37.9% Reduced
CAPRCapricor Therapeutics, Inc.0.26%$2.9m122.2K−1.3% Reduced
DNLIDenali Therapeutics Inc.0.23%$2.6m101.0KNew
SNDXSyndax Pharmaceuticals Inc0.23%$2.6m118.4K−51.7% Reduced
AMLXAmylyx Pharmaceuticals, Inc.0.22%$2.6m143.7K−1.1% Reduced
TARSTarsus Pharmaceuticals, Inc.0.22%$2.6m40.6K−49.4% Reduced
OMOutset Medical, Inc.0.22%$2.5m582.1K−2.1% Reduced
OMDAOmada Health, Inc.0.22%$2.5m114.4KNew
ERASErasca, Inc.0.21%$2.5m134.1KNew
CORCencora0.18%$2.1m7.4KNew
BCRXBiocryst Pharmaceuticals Inc0.18%$2.1m207.4KNew
OMCLOmnicell, Inc.0.18%$2.0m49.0KNew
CVRXCvrx, Inc.0.17%$1.9m369.6KNew
HIMSHims & Hers Health, Inc.0.15%$1.7m49.5KNew
MLYSMineralys Therapeutics, Inc.0.15%$1.7m62.4K−56.3% Reduced
TECXTectonic Therapeutic, Inc.0.14%$1.6m45.6K−1.1% Reduced
QUREUniqure N.V.0.11%$1.2m26.4K−38.1% Reduced
RZLTRezolute, Inc.0.06%$661,903127.3K−1.1% Reduced
CRBUCaribou Biosciences, Inc.0.05%$624,249354.7K−63.0% Reduced
CompanyBought (value)Shares
ASNDAscendis Pharma A/s$62.2m233.2K
HUMHumana$37.5m94.4K
MTDMettler Toledo$17.0m13.3K
MRKMerck & Co.$16.3m127.1K
CYTKCytokinetics Inc$16.3m191.7K
LNTHLantheus Holdings, Inc.$16.2m146.4K
CVSCVS Health$14.2m137.5K
ICLRIcon PLC$13.7m79.0K
UNHUnitedHealth Group$12.6m30.2K
GILDGilead Sciences$11.5m90.9K
SYKStryker Corporation$10.9m34.7K
TFXTeleflex Inc$10.1m79.7K
IRTCIrhythm Holdings, Inc.$7.8m65.2K
WATWaters Corporation$7.5m20.1K
WSTWest Pharmaceutical Services$7.4m20.7K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanySold (value)Shares
THCTenet Healthcare Corp−$50.9m−272.0K
LLYLilly (Eli)−$31.8m−26.5K
PENPenumbra Inc−$25.1m−79.6K
GKOSGlaukos Corp−$23.2m−215.7K
CMPSCompass Pathways plc−$15.8m−1.12M
NEONeogenomics Inc−$13.2m−1.78M
AXSMAxsome Therapeutics, Inc.−$10.9m−44.7K
NTRANatera, Inc.−$10.3m−37.9K
DXCMDexcom−$9.4m−149.7K
AMRXAmneal Pharmaceuticals, Inc.−$7.8m−449.4K
INDVIndivior Pharmaceuticals, Inc.−$7.1m−173.5K
BLLNBilliontoone, Inc.−$7.0m−88.1K
CAHCardinal Health−$6.7m−31.9K
ALHCAlignment Healthcare, Inc.−$6.3m−359.8K
PSNLPersonalis, Inc.−$5.5m−870.1K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanyValue last quarterShares
GKOSGlaukos Corp$23.2m215.7K
NEONeogenomics Inc$13.2m1.78M
DXCMDexcom$9.4m149.7K
BLLNBilliontoone, Inc.$7.0m88.1K
CAHCardinal Health$6.7m31.9K
ALHCAlignment Healthcare, Inc.$6.3m359.8K
PSNLPersonalis, Inc.$5.5m870.1K
MDLNMedline Inc.$3.9m86.8K
GMEDGlobus Medical Inc$1.5m16.9K
  • Health Care100.0%

Share of the value held in companies we cover, by sector.

PeriodCopy, a yearS&P 500SharpeS&P 500Biggest dropBeta
Whole backtestFebruary 28, 2014 to November 2, 2026+11.1%+13.6%0.530.74−28.2%0.94
2018 onwardsJanuary 5, 2018 to November 2, 2026+10.3%+13.9%0.440.66−28.2%0.92
Last three yearsNovember 3, 2023 to November 2, 2026+19.3%+21.8%0.841.16−18.8%0.67
Last yearNovember 7, 2025 to November 2, 2026+28.4%+14.2%1.330.84−12.6%0.65

From SEC Form 13F data sets. A 13F lists long positions in US-listed shares at the quarter's end, filed up to 45 days later; it does not show shorts, cash, bonds, non-US holdings or trades within the quarter. Positions in companies outside our coverage are not listed here. Research, not investment advice.